These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15759379)

  • 1. Chemical liver function tests and epidemiologic studies of HBsAg positive blood donors.
    Kim YC; Kim JS; Kim SH; Lee SM; Shim WB; Moon HK
    Korean J Intern Med; 1986 Jan; 1(1):67-71. PubMed ID: 15759379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical studies of apparently 'healthy' blood donors with reference to liver function tests and immunoglobulins.
    Ezeoke AC
    Ric Clin Lab; 1985; 15(3):267-73. PubMed ID: 4081521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical, laboratory and liver histology of HBsAg-positive volunteer blood donors in Belo Horizonte, State of Minas Gerais, Brazil].
    Paz MO; Galizzi Filho J; Simonetti JP; Simonetti SR; de Santana ZM; Barbosa MM; de Carvalho DG; Toppa NH
    Rev Hosp Clin Fac Med Sao Paulo; 1998; 53(6):311-6. PubMed ID: 10413947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of anicteric hepatitis following blood transfusion.
    Somayaji BN; Stone WD; Glover PB
    Gut; 1967 Dec; 8(6):614-7. PubMed ID: 6079814
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selection of liver function tests for diagnosis of various liver diseases].
    Nihon Naika Gakkai Zasshi; 1990 Aug; 79(8):1059-68. PubMed ID: 1700046
    [No Abstract]   [Full Text] [Related]  

  • 6. [Unresolved questions on the diagnosis of hepatitis in donors].
    Khersonskaia RIa; Zverkova AS; Fedorovskaia EA; Rogotskaia LT; Zakharenko NI
    Vopr Virusol; 1988; 33(6):690-2. PubMed ID: 3247688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory treatment of HBsAg positive chronic hepatitis with specific substance Maruyama (SSM).
    Okumura H; Satomura K; Aramaki T; Katsuta Y; Terada H; Sekiyama T; Akaike M; Otake M; Fujita K; Maruyama C
    Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):192-9. PubMed ID: 6736212
    [No Abstract]   [Full Text] [Related]  

  • 8. Etiology of and risk factors for transient and persistent aminotransferase elevation in a population of virus-free blood donors: a multicentre study.
    Morisco F; Stroffolini T; Mele A; Taliani G; Smedile A; Caronna S; Tosti ME; Niro G; Levrero M; Fiorillo MT; Amoruso DC; Ascione A; Caporaso N
    Dig Liver Dis; 2010 Jun; 42(6):441-5. PubMed ID: 19643684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of voluntary blood donors for serum hepatitis carrier state by liver function tests.
    Jolly JG; Sharma NN
    Indian J Med Res; 1972 Nov; 60(11):1592-6. PubMed ID: 4654629
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical significance of positive SGOT screening test in blood donors].
    Pintera J; Valnícek S; Vacl J; Horecká J; Králícková J
    Vnitr Lek; 1969 Sep; 15(9):881-6. PubMed ID: 5824799
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis-associated antigen (Australia antigen) in Massachusetts blood donors.
    Kliman A; Reid NR; Lilly C; Morrison J
    N Engl J Med; 1971 Sep; 285(14):783-5. PubMed ID: 5567264
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B surface antigen in pregnant women.
    Hsieh FJ; Hsieh SO; Wang KY
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1979 Mar; 12(1):1-5. PubMed ID: 583270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serologic examinations of blood donors. III. Detection of liver damage in the blood of blood donors].
    Falser N
    Infusionstherapie (1973); 1974 Dec; 1(8):666-70. PubMed ID: 4142947
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with immunoprophylaxis and interferon therapy after liver transplantation in HBsAG positive patients.
    Neuhaus P; Steffen R; Blumhardt G; Bechstein W; Keck H; Lemmens HP; Neuhaus R; Lobeck H; König V; Hopf U
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1522-4. PubMed ID: 1671180
    [No Abstract]   [Full Text] [Related]  

  • 15. De novo hepatitis B virus infection after orthotopic liver transplantation.
    Liu PP; Chen CL; Chen YS; Tai DI
    Transplant Proc; 1996 Jun; 28(3):1684-6. PubMed ID: 8658839
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
    Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
    J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral hepatitis in HBsAg-positive renal transplant patients treated with cyclosporin and steroids.
    Sandrini S; Callea F; Cristinelli L; Savoldi S; Setti G; Scaini P; Scolari F; Scalzini A; Pizzoccolo G; Maiorca R
    Nephrol Dial Transplant; 1990; 5(7):525-30. PubMed ID: 2130300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Australia antigen in blood donors].
    Kacperska E; Klenowska Z; Bragiel I; Seyfriedowa H
    Acta Haematol Pol; 1971; 2(1):3-9. PubMed ID: 5005645
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspartate transaminase (SGO-T) and alanine transaminase (SGP-T) in blood donors, Siriraj Hospital.
    Viranuvatti V; Lekayanonda S
    Am J Proctol; 1966 Dec; 17(6):499-502. PubMed ID: 5980695
    [No Abstract]   [Full Text] [Related]  

  • 20. Interest of enzymatic determinations: OCT, GOT, GPT and observations of the presence of Australia antigen relating to viral hepatitis in blood donors.
    Otto-Servais M; Plomteux G; Brocteur J; Buret J; Lennes G; Andre A; Heusghem C
    Vox Sang; 1970; 19(3):338-44. PubMed ID: 5502764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.